Nuvasive Inc (NUVA) Return on Investment ROI from the second quarter of 2023 to second quarter of 2022 and for the year 2023, average high and low, overall ranking from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Nuvasive Inc  (NASDAQ: NUVA)


Nuvasive Inc's ROI from its second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Nuvasive Inc's ROI in the second quarter of 2023?
Nuvasive Inc achieved a return on average invested assets (ROI) of 2.17 % in its second quarter of 2023, this is above NUVA's average return on investment of 0.89%.
Nuvasive Inc invested over the 12 months ending in its second quarter of 2023 $1,311 million

ROI has improved compared to 1.5% in the first quarter of 2023, due to net income growth.

Within the Healthcare sector 176 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2023 quarter, so far to 1994, from total ROI ranking in the first quarter of 2023 at 2315.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Investment Change TTM -27.91 % -30.64 % -23.27 % -14.03 % -4.26 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1,338 1,319 1,313 1,276 1,473
Return On Investment (TTM) 2.17 % 1.5 % 2.71 % -1.23 % -2.2 %
NUVA's Overall Ranking # 1994 # 2315 # 2364 # 3271 # 3495
Seq. Investment Change TTM -2.5 % -9.93 % -9.68 % -9.11 % -6.19 %
Seq. Net Income Change TTM 40.89 % -50.03 % - - -
Net Income (TTM) in Millions 28 20 40 -20 -40

NUVA Company Profile >> Back to NUVA Roi Comparisons >> See Annual NUVA Return On Investment



Return On Investment NUVA's Ranking
Within: No.
Industry # 60
Sector # 177
Overall # 1994

Return On Investment Statistics
High Average Low
9.89 %
0.89 %
-8.18 %
(Jun 30 2011)   (Jun 30 2012)







Financial Statements
Nuvasive Inc's II. Quarter Investments $ 1,338 Millions NUVA's Balance sheet
Nuvasive Inc's II. Quarter Income $ 7 Millions Quarterly NUVA's Income Statement
NUVA's Income by Division See NUVA's Income by Division


NUVA Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 1,313 1,953 1,861 1,678 1,528
Y / Y Investment Growth -32.77 % 4.93 % 10.91 % 9.81 % 3.11 %
Net Income in Millions 40 -64 -37 65 12
Y / Y Net Income Growth - - - 422.75 % -84.64 %
Annual Return On Investment 3.08 % -3.28 % -2 % 3.89 % 0.82 %


Annual Roi Comment
In the fiscal year 2022 ROI improved to 3.08 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NUVA's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NUVA's Competitors
Subscribers only: Roi for Nuvasive Inc's Suppliers
Subscribers only: Return On Investment for NUVA's Customers

Other Ratios
NUVA's Roa NUVA's Inventory Turnover Ratio NUVA's Growth Rates NUVA's Dividend Statistics
NUVA's Profitability Ratios NUVA's Asset Turnover Ratio NUVA's Dividend Growth
NUVA's Roe NUVA's Valuation Ratios NUVA's Financial Strength Ratios NUVA's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2023, within Healthcare Sector ROI
Merit Medical Systems Inc  5.90 %
Teleflex Incorporated  5.86 %
Acadia Healthcare Company Inc   5.82 %
Horizon Therapeutics Public Limited Company  5.71 %
Iqvia Holdings Inc   5.66 %
Kewaunee Scientific Corporation  5.61 %
Lifevantage Corp  5.58 %
Repligen Corp  5.47 %
Ensign Group Inc  5.27 %
Privia Health Group Inc   5.23 %
Sensus Healthcare Inc   4.99 %
U S Physical Therapy Inc  4.74 %
Northview Acquisition Corp  4.71 %
Labcorp Holdings Inc   4.70 %
Davita Inc   4.68 %
Masimo Corp  4.62 %
Third Harmonic Bio Inc   4.61 %
Pediatrix Medical Group Inc   4.58 %
Medtronic Plc  4.52 %
Revvity Inc  4.41 %
Conmed Corporation  4.38 %
Pacific Health Care Organization Inc  4.36 %
Lakeland Industries Inc   4.31 %
Envista Holdings Corporation  4.29 %
Viatris Inc   4.28 %
Tenet Healthcare Corp  4.23 %
Phibro Animal Health Corporation  4.18 %
Cryo cell International Inc   4.15 %
Merck and Co Inc   4.12 %
Eagle Pharmaceuticals inc   4.00 %

Date modified: 2026-09-12T06:12:52+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.